✦ LIBER ✦

Commentary on “Optimal design of clinical trials for drugs designed to slow the course of Alzheimer’s disease”

✍ Scribed by Eric R. Siemers

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary on “Optimal design of clinica

✍ Christopher M. Clark; Domenico Pratico; Lesley M. Shaw; Susan Leight; Sharon X. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Optimal design of clinical trials for dr

✍ Richard C. Mohs; Claudia Kawas; Maria C. Carrillo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 188 KB

The epidemiology of Alzheimer’s disease:

✍ Kristine Yaffe; Michael Tocco; Ronald C. Petersen; Catherine Sigler; Leah C. Bur 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 193 KB

PL-05-02: The evolution of Alzheimer's d

✍ Paul S. Aisen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Application of Clinical Trial Simulation

✍ Peter Lockwood; Wayne Ewy; David Hermann; Nick Holford 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 353 KB

Commentary on “Design of comprehensive A

✍ Marwan N. Sabbagh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB